CLOV CLOVER HEALTH INV CORP

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network

WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new community-based pharmacy pilot program across New Jersey. Built in partnership with IPC Digital Health™, a division of Independent Pharmacy Cooperative (IPC), this initiative is designed to help seniors better manage their medications and stay healthier at home, supported by the local pharmacies they know and trust.

The program will be anchored by IPC’s iCare+™ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey. These local pharmacies will deploy innovative care tools and virtual services that help Clover members with chronic conditions stay on track with their medications and avoid unnecessary hospital visits.

“This is more than a new program—it’s a new model for how we support our New Jersey members,” said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “By working with the pharmacists who are already embedded in our communities, we can deliver better care, deliver amazing customer experiences and support the independent businesses that keep New Jersey strong.”

Participating iCare+ pharmacies will use real-time tools, powered by Clover Assistant data and AI models, to monitor prescription fills, identify adherence gaps, and collaborate with local doctors and Clover’s care teams. The goal: make it easier for seniors to get the right medications at the right time, while keeping their care close to home.

“Clover Health understands that innovation doesn’t always mean centralization,” said Ashton Maaraba, President of IPC Digital Health. “This partnership helps New Jersey’s independent pharmacies lead the way in delivering smarter, more connected care.”

This new program is part of Clover’s broader commitment to investing in New Jersey communities, by combining modern technology, local relationships, and a belief that healthcare should feel personal again.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on  and , as well as the earlier identification and management of  and .

Visit:

Investor Relations:

Ryan Schmidt

Press Inquiries:

About IPC Digital Health™

IPC Digital Health™ is the innovation arm of the Independent Pharmacy Cooperative, the country’s largest GPO owned by independent pharmacies. Through its iCare+™ platform, IPC delivers digital health solutions that strengthen the clinical and financial future of community pharmacies. Learn more at



EN
09/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Launches New Jersey Community Pharmacy Program in Partne...

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new community-based pharmacy pilot program across New Jersey. Built in partnership with IPC Digital Health™, a division of Independent Pharmacy Cooperative (IPC), this initiative is designed to help seniors better manage their medications and stay healthier at ...

 PRESS RELEASE

Clover Health to Report Second Quarter 2025 Financial Results on Augus...

Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025 WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Tuesday, August 5, 2025. Company management will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Second Quarter 2025 Conference Call and Webcast Details: What: Clover Health’s...

 PRESS RELEASE

Clover Health Set to Join Russell 3000® Index

Clover Health Set to Join Russell 3000® Index WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effective after the US market opens today, June 30, 2025, as part of the 2025 Russell indexes reconstitution. Annual reconstitution of the Russell indexes captures the 4,000 largest US stocks as of April 30, 2025, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, also results in automat...

 PRESS RELEASE

Clover Health Reports First Quarter 2025 Results and Improves Full Yea...

Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjust...

 PRESS RELEASE

Primary Care Physician Use of Counterpart Assistant Technology Associa...

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower) and readmissions (25% lower) in heart failure patients WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Heal...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch